VolitionRx Limited Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- VolitionRx Limited stock issued during period, value, new issues for the quarter ending 2026-06-30 was $5.46M, a 8906.74% increase year-over-year.
- VolitionRx Limited stock issued during period, value, new issues for the quarter ending 2026-03-31 was $5.17M, a 116.96% increase year-over-year.
- VolitionRx Limited stock issued during period, value, new issues for the quarter ending 2025-09-30 was $2.01M.
- VolitionRx Limited stock issued during period, value, new issues for the quarter ending 2025-06-30 was $60.60K, a 89.72% decline year-over-year.
- VolitionRx Limited stock issued during period, value, new issues for fiscal 2025 was $11.17M, a 31.89% increase from fiscal 2024.
- VolitionRx Limited stock issued during period, value, new issues for fiscal 2024 was $8.47M.
- VolitionRx Limited stock issued during period, value, new issues for fiscal 2022 was $6.74M, a 70.99% decline from fiscal 2021.
- VolitionRx Limited stock issued during period, value, new issues for fiscal 2021 was $23.22M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $5.46M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $5.17M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $11.17M 10-K · filed 2026-03-31 | |
| 2025-09-30 | $2.01M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $60.60K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $2.38M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $8.47M 10-K · filed 2026-03-31 | |
| 2024-06-30 | $589.49K 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $15.73K 10-Q · filed 2025-11-13 | |
| 2023-03-31 | $8.43M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $6.74M 10-K · filed 2024-03-25 | |
| 2022-09-30 | $5.95M 10-Q · filed 2022-11-14 | |
| 2022-03-31 | $9.47K 10-Q · filed 2023-05-10 | |
| 2021-12-31 | $23.22M 10-K · filed 2023-03-15 | |
| 2021-09-30 | $252.93K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $854.71K 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $20.33M 10-Q · filed 2022-11-14 | |
| 2020-06-30 | $14.23M 10-Q · filed 2021-11-10 | |
| 2019-12-31 | $16.59M 10-K · filed 2020-02-20 | |
| 2019-09-30 | $4.83M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $5.00M 10-Q · filed 2020-08-13 | |
| 2019-03-31 | $6.66M 10-Q · filed 2020-08-13 | |
| 2018-12-31 | $17.25M 10-K · filed 2020-02-20 | |
| 2018-09-30 | $9.00M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $7.80M 10-Q · filed 2019-11-12 | |
| 2012-12-31 | $1.02M 10-Q · filed 2013-05-06 | |
| 2011-12-31 | $150.00K 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |